Gaurav Singh, MD, MPH, a Mohs micrographic surgeon and dermatologist and assistant clinical professor in the department of surgery at City of Hope Cancer Center in Chicago, Illinois, highlights his presentation at the American Academy of Dermatology titled, “Beyond the Surgery: Advances in Cutaneous SCC Risk Stratification.” In addition, he explains the impact of the DecisionDx-SCC tool to enhance risk stratification for patients with cutaneous squamous cell carcinoma (SCC). He also discusses future directions and emerging treatment options for cutaneous SCC.
Topics Covered:
- Recent literature showcasing enhanced risk stratification in cutaneous squamous cell carcinoma
- Treatment decision-making in cutaneous squamous cell carcinoma
- Impact of DecisionDx-SCC test on patient outcomes